Skip to main content
. 2010 Dec 13;5(12):e14296. doi: 10.1371/journal.pone.0014296

Figure 6. nb and nbl mRNAs rescue the hematopoietic phenotypes of nb/nbl morphants.

Figure 6

A–B. Percentages of Tg(gata1:dsRed) with hematopoietic defects obtained in rescue experiments (A) and corresponding percentages of embryos which rescue the hematopoietic phenotype (B). Injection of nb/nbl MO (0.8 pmol/embryo) produced ∼68% of Tg(gata1:dsRed) embryos with hematopoietic defects at 48 hpf (n = 142). Co-injection of 1 ng/embryo of numb-EGFP mRNA and 0.8 pmol/embryo nb/nbl MO (n = 114) produced ∼35% of embryos with hematopoietic defects (A) that correspond to ∼49% of rescue (B). ∼49% of embryos co-injected with 170 pg/embryo of numblike mRNA and 0.8 pmol/e nb/nbl MO (n = 105) showed hematopoietic defects (A) corresponding to ∼28% of rescue (B). * p<0.05 vs nb/nbl MO no defects, **p<0.01 vs nb/nbl MO no defects, #p<0.05 vs nb/nbl MO defects, ##p<0.01 vs nb/nbl MO defects.